This inventor holds 1 USPTO granted patent and 10 published patent applications and 2 EPO patents. Top assignee: Genfit S.a.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Sébastien Barradeau
Introduction
Sébastien Barradeau is an innovative inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of obesity. His work focuses on the use of selective inhibitors to address health issues related to obesity.
Latest Patents
Sébastien Barradeau holds a patent for the "Use of 15-lipoxygenase inhibitors for treating obesity." This invention specifically targets abdominal visceral obesity and involves the use of selective 15-lipoxygenase (LO) inhibitors to prepare medicines that are effective in treating obesity and its associated consequences.
Career Highlights
Throughout his career, Sébastien has worked with notable companies such as Genfit S.A. and Genomic Vision. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Sébastien has collaborated with talented individuals, including Geneviève Martin and Sakina Sayah-Jeanne. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Sébastien Barradeau is a prominent inventor whose work in obesity treatment showcases his dedication to improving health outcomes. His innovative approach and collaborations highlight the importance of research in addressing significant health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile